Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-20

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for BUPROPION HYDROCHLORIDE from Epic Pharma LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)